Enwei Pharmaceutical Co Ltd
SZSE:301331
Dividends
Dividend Yield
Enwei Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Enwei Pharmaceutical Co Ltd
Payout Ratio
Enwei Pharmaceutical Co Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Enwei Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Enwei Pharmaceutical Co Ltd
| Average Annual Return | -5.66% |
| Standard Deviation of Annual Returns | 9.88% |
| Max Drawdown | -47% |
| Market Capitalization | 790.7m CNY |
| Shares Outstanding | 28 393 022 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Enwei Pharmaceutical Co Ltd's latest stock split occurred on May 23, 2024
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Enwei Pharmaceutical Co Ltd traded at 41.56 per share. Afterward, the share price was about 27.47.
The adjusted shares began trading on May 23, 2024. This was the only stock split in Enwei Pharmaceutical Co Ltd's history.